BDMD Share Price Performance
US$1.99
-9.08 (-82.02%)
Price US$1.99
Share PriceUS$1.99
BDMD Community Narratives
There are no narratives available yet.
Recent BDMD News & Updates
No updates
Baird Medical Investment Holdings Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.46
- Gross Margin
- 88.16%
- Net Profit Margin
- 33.62%
- Debt/Equity Ratio
- 51.5%
Baird Medical Investment Holdings Limited Competitors
About BDMD
- Founded
- 2012
- Employees
- 143
- CEO
- WebsiteView website
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Chinese Market Performance
- 7 Days: -0.4%
- 3 Months: 10.1%
- 1 Year: 33.5%
- Year to Date: 13.0%
In the last week, the market has been flat. More promisingly, the market is up 33% over the past year. Earnings are forecast to grow by 24% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading